Melazyme
PrivateLast Round
Seed
May 14, 2026
Total Funding Raised
$2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Melazyme operates in Healthcare & Life Sciences and is based in Utah. Its latest recorded funding round was a Seed round in May 2026.
Melazyme is a biotechnology company that uses a precision fermentation platform to develop functional biomolecules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Fashion & Beauty, Water Treatment, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Melazyme Comparables
Compare Melazyme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OXYCO | 84% | |
| MelaTech LLC | 73% | |
| Insempra | 70% |
For institutional investors. Book with your work email.
Melazyme Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Melazyme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stellaris Venture Partners | Seed |
| Plug and Play Tech Center | Seed |
| SeaX Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
$2M round led by SeaX Ventures
For institutional investors. Book with your work email.
Melazyme Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Melazyme's valuation, stock price, and market status.
Is Melazyme a public or private company?
Melazyme is a private company.
What is the current stock price of Melazyme?
Melazyme is a private company, so its shares have no public market price. Caplight tracks Melazyme's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Melazyme worth (valuation)?
Valuation information for Melazyme is not publicly available.
Can I buy Melazyme stock?
Melazyme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Melazyme's last funding round?
Melazyme's most recent funding round was Seed on May 14, 2026.
Who are the main investors in Melazyme?
Key investors in Melazyme include SeaX Ventures.
Will Melazyme IPO soon?
No public IPO plans have been announced for Melazyme.
How can I track Melazyme secondary market activity?
Caplight tracks bids, offers, and trades in Melazyme's shares on secondary markets.